פורמולציות מאוחסנות המכילות אוקטראוטיד ושני פולימרים פולילקטיד–קו–גליקוליד לינארים
- 专利权人:
- NOVARTIS AG
- 发明人:
- 申请号：
- IL21303411
- 公开号：
- IL213034A
- 申请日:
- 2011.05.19
- 申请国别(地区):
- IL
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and two different linear polylactide-co-glycolide polymers (PLGAs).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- OCTREOTIDE DEPOT FORMULATION WITH CONSTANTLY HIGH EXPOSURE LEVELS
- Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
- sustained release formulation comprising octreotide and three linear coglycolide polylactpide polymers
- SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND THREE LINEAR POLYLACTIDE-CO-GLYCOLIDE POLYMERS
- Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers
